VivoSeq
Other

Arthroscopic Surgery

1

Pipeline Programs↗

2

Active Trials↗

3

Companies Involved↗

Arthroscopic Surgery is an early-stage landscape with 1 program across 3 companies. The most active players are Eli Lilly, Taksim Egitim ve Arastirma Hastanesi, Sherin Refaat.

Intelligence

Pipeline Metrics

Competitive Density

16/100

Pipeline Velocity

15/100

Mech. Concentration

N/A

Completion Rate

100/100

Attrition Rate

0/100

Competition

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Key Players

Top Companies Companies ranked by the number of pipeline programs they run for this disease.

Eli Lilly logo

Eli Lilly

1 program

ApprovedT

Taksim Egitim ve Arastirma Hastanesi

0 programs

PreclinicalS

Sherin Refaat

0 programs

Preclinical

Pipeline

Programs by Phase

Preclinical1

Bupivacaine %0.25 (isobaric)

University of Novi Sad

Phase 1
No programs
Phase 2
No programs
Phase 3
No programs
Approved
No programs

Analysis

Trial Status

3

clinical trials

Not yet recruiting1 · 33%
Completed1 · 33%
Recruiting1 · 33%

Clinical Trials

Trial Activity

Novel Analgesic Approaches in Shoulder Surgery: Erector Spinae Plane Block Versus Infraspinatus-Teres Minor Interfascial Plane Block
Not yet recruiting·TTaksim Egitim ve Arastirma Hastanesi·Preclinical·NCT07688395·100 enrolled
Is Pericapsular Nerve Group (PENG) Block Superior to Interscalene Nerve Block Regarding Motor Power Affection in Shoulder Scope Surgeries? A Randomised Comparative Study.
Completed·—·Preclinical·NCT07057947·60 enrolled
Effectiveness of Per-Operative Bupivicaine in Reducing Postoperative Pain at Port Site and Improving Mobility in Knee Arthoscopic Procedures
Recruiting·KKhyber Teaching Hospital·Approved·NCT07090928·60 enrolled

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)